Literature DB >> 24302726

Sympathetic activation induces skeletal Fgf23 expression in a circadian rhythm-dependent manner.

Masanobu Kawai1, Saori Kinoshita, Shigeki Shimba, Keiichi Ozono, Toshimi Michigami.   

Abstract

The circadian clock network is well known to link food intake and metabolic outputs. Phosphorus is a pivotal nutritional factor involved in energy and skeletal metabolisms and possesses a circadian profile in the circulation; however, the precise mechanisms whereby phosphate metabolism is regulated by the circadian clock network remain largely unknown. Because sympathetic tone, which displays a circadian profile, is activated by food intake, we tested the hypothesis that phosphate metabolism was regulated by the circadian clock network through the modification of food intake-associated sympathetic activation. Skeletal Fgf23 expression showed higher expression during the dark phase (DP) associated with elevated circulating FGF23 levels and enhanced phosphate excretion in the urine. The peaks in skeletal Fgf23 expression and urine epinephrine levels, a marker for sympathetic tone, shifted from DP to the light phase (LP) when mice were fed during LP. Interestingly, β-adrenergic agonist, isoproterenol (ISO), induced skeletal Fgf23 expression when administered at ZT12, but this was not observed in Bmal1-deficient mice. In vitro reporter assays revealed that ISO trans-activated Fgf23 promoter through a cAMP responsive element in osteoblastic UMR-106 cells. The mechanism of circadian regulation of Fgf23 induction by ISO in vivo was partly explained by the suppressive effect of Cryptochrome1 (Cry1) on ISO signaling. These results indicate that the regulation of skeletal Fgf23 expression by sympathetic activity is dependent on the circadian clock system and may shed light on new regulatory networks of FGF23 that could be important for understanding the physiology of phosphate metabolism.

Entities:  

Keywords:  Bone; Circadian Rhythms; Cryptochrome1; FGF23; Fibroblast Growth Factor (FGF); Nerve; Parathyroid Hormone; Phosphate Metabolism; Sympathetic Activity

Mesh:

Substances:

Year:  2013        PMID: 24302726      PMCID: PMC3894328          DOI: 10.1074/jbc.M113.500850

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus.

Authors:  F Damiola; N Le Minh; N Preitner; B Kornmann; F Fleury-Olela; U Schibler
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

2.  Leptin regulates bone formation via the sympathetic nervous system.

Authors:  Shu Takeda; Florent Elefteriou; Regis Levasseur; Xiuyun Liu; Liping Zhao; Keith L Parker; Dawna Armstrong; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

3.  Effect of starvation and food intake on sympathetic activity.

Authors:  T Sakaguchi; K Arase; J S Fisler; G A Bray
Journal:  Am J Physiol       Date:  1988-08

Review 4.  Protein tyrosine kinase structure and function.

Authors:  S R Hubbard; J H Till
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

5.  Relation of obesity and diet to sympathetic nervous system activity.

Authors:  R J Troisi; S T Weiss; D R Parker; D Sparrow; J B Young; L Landsberg
Journal:  Hypertension       Date:  1991-05       Impact factor: 10.190

Review 6.  Cellular bioenergetics as a target for obesity therapy.

Authors:  Yu-Hua Tseng; Aaron M Cypess; C Ronald Kahn
Journal:  Nat Rev Drug Discov       Date:  2010-06       Impact factor: 84.694

7.  FGF23 is processed by proprotein convertases but not by PHEX.

Authors:  Anna Benet-Pagès; Bettina Lorenz-Depiereux; Hans Zischka; Kenneth E White; Michael J Econs; Tim M Strom
Journal:  Bone       Date:  2004-08       Impact factor: 4.398

8.  Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

Authors:  Tobias Larsson; Ulf Nisbeth; Osten Ljunggren; Harald Jüppner; Kenneth B Jonsson
Journal:  Kidney Int       Date:  2003-12       Impact factor: 10.612

9.  Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.

Authors:  Takashi Shimada; Makoto Kakitani; Yuji Yamazaki; Hisashi Hasegawa; Yasuhiro Takeuchi; Toshiro Fujita; Seiji Fukumoto; Kazuma Tomizuka; Takeyoshi Yamashita
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

10.  Transplanted suprachiasmatic nucleus determines circadian period.

Authors:  M R Ralph; R G Foster; F C Davis; M Menaker
Journal:  Science       Date:  1990-02-23       Impact factor: 47.728

View more
  28 in total

Review 1.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

Review 2.  Control of phosphate balance by the kidney and intestine.

Authors:  Ichiro Kaneko; Sawako Tatsumi; Hiroko Segawa; Ken-Ichi Miyamoto
Journal:  Clin Exp Nephrol       Date:  2016-11-30       Impact factor: 2.801

Review 3.  Obstructive sleep apnea and metabolic bone disease: insights into the relationship between bone and sleep.

Authors:  Christine M Swanson; Steven A Shea; Katie L Stone; Jane A Cauley; Clifford J Rosen; Susan Redline; Gerard Karsenty; Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2015-02       Impact factor: 6.741

Review 4.  Impact of the Autonomic Nervous System on the Skeleton.

Authors:  Florent Elefteriou
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 5.  The importance of the circadian system & sleep for bone health.

Authors:  Christine M Swanson; Wendy M Kohrt; Orfeu M Buxton; Carol A Everson; Kenneth P Wright; Eric S Orwoll; Steven A Shea
Journal:  Metabolism       Date:  2017-12-09       Impact factor: 8.694

6.  A Controlled Increase in Dietary Phosphate Elevates BP in Healthy Human Subjects.

Authors:  Jaber Mohammad; Roberto Scanni; Lukas Bestmann; Henry N Hulter; Reto Krapf
Journal:  J Am Soc Nephrol       Date:  2018-07-18       Impact factor: 10.121

7.  24-hour profile of serum sclerostin and its association with bone biomarkers in men.

Authors:  C Swanson; S A Shea; P Wolfe; S Markwardt; S W Cain; M Munch; C A Czeisler; E S Orwoll; O M Buxton
Journal:  Osteoporos Int       Date:  2017-07-26       Impact factor: 4.507

8.  Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study.

Authors:  Rajat Deo; Ronit Katz; Ian H de Boer; Nona Sotoodehnia; Bryan Kestenbaum; Kenneth J Mukamal; Michel Chonchol; Mark J Sarnak; David Siscovick; Michael G Shlipak; Joachim H Ix
Journal:  Am J Kidney Dis       Date:  2015-01-05       Impact factor: 8.860

Review 9.  New concepts in regulation and function of the FGF23.

Authors:  Sanaz Dastghaib; Farhad Koohpeyma; Mesbah Shams; Forough Saki; Aliakbar Alizadeh
Journal:  Clin Exp Med       Date:  2022-06-16       Impact factor: 3.984

10.  CLOCK-BMAL1 regulates circadian oscillation of ventricular arrhythmias in failing hearts through β1 adrenergic receptor.

Authors:  Zihao Zhou; Jiamin Yuan; Didi Zhu; Yanhong Chen; Zhiyong Qian; Yao Wang; Peibin Ge; Quanpeng Wang; Xiaofeng Hou; Jiangang Zou
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.